WG
BIVV

Winton Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Winton Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-136,278
Closed -$7.35M – 1185
2017
Q4 		$7.35M Buy
136,278
+86,223
+172% +$4.72M 0.21% 130
2017
Q3 		$2.86M Buy
50,055
+30,152
+151% +$1.77M 0.09% 244
2017
Q2 		$1.2M Buy
19,903
+7,100
+55% +$404K 0.04% 321
2017
Q1 		$697K Buy
+12,803
New +$631K 0.02% 349

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Winton Group's BIVV Position: Q1 2018 in Review

Winton Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 136,278 shares — an estimated $7.35M sold.

Winton Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7.35M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Winton Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Winton Group sold 136,278 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $7.35M.
  • Winton Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Winton Group's Bioverativ Inc. Common Stock position peaked at $7.35M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Winton Group's 13F filing for Q1 2018, filed 21 May 2018.